BS
Bode Ireti Shobayo
Research areas: Medicine · Infectious Diseases · Virology and Viral Diseases · Viral Infections and Outbreaks Research · Viral Infections and Vectors
0000-0002-4864-0248
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (34)
- First laboratory-confirmed fatal dengue virus infection and its implications for national arboviral surveillance in Liberia Save
- Knowledge, Attitudes, and Practices Related to Antibiotic Use and Antibiotic Resistance Among Adults in Communities of Montserrado County, Liberia: A Household-Based Cross-Sectional Study Save
- Perspectives and Challenges of Healthcare Professionals, Patients, and Caregivers Regarding Utilizing Antibiotics and Implementing Antibiotic Stewardship in Healthcare Facilities in Low- and Middle-Income Countries: A Systematic Review of Qualitative Stu… Save
- Adoption and use of the 7-1-7 timeliness metrics for detection, notification, and early response actions to public health events: an observational study in Liberia, January 2024– June 2025 Save
- The Evolutionary Dynamics and Regional Spread of Mpox in Africa: Insights from Multi-country Genomic Surveillance Save
- Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial. Save
- Assessment of Knowledge, Attitudes, and Practices on Antibiotic Use and Resistance Among Healthcare Workers in Monrovia, Liberia: A Facility-Based Cross-Sectional Study Save
- Monkeypox Virus Clade IIa Infections, Liberia, 2023-2024. Save
- Epidemiological characteristics and hospital outcomes of hospitalized Lassa fever cases during the 2022-2023 outbreak in Liberia Save
- Baseline Seroprevalence of Arboviruses in Liberia Using a Multiplex IgG Immunoassay Save
- Adoption and use of the 7-1-7 timeliness metrics for detection, notification, and early response actions to public health events: an observational study in Liberia, January 2024– June 2025 Save
- Monkeypox Virus Clade IIa Infections, Liberia, 2023--2024 Save
- Epidemiological characteristics and hospital outcomes of hospitalized Lassa fever cases during the 2022-2023 outbreak in Liberia Save
- Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults. Save
- A Serological Multiplexed Immunoassay (MIA) Detects Antibody Reactivity to SARS-CoV-2 and Other Viral Pathogens in Liberia and Is Configurable as a Multiplexed Inhibition Test (MINT) Save
- Descriptive Analysis of Measles Outbreak in Liberia, 2022 Save
- Immunogenicity and vaccine shedding after 1 or 2 doses of rVSV$Δ$G-ZEBOV-GP Ebola vaccine (ERVEBO®): results from a phase 2, randomized, placebo-controlled trial in children and adults Save
- Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases Save
- Trend of Lassa fever cases and factors associated with mortality in Liberia, 2016 - 2021: a secondary data analysis. Save
- Knowledge, attitude, and practice towards hepatitis B virus among healthcare workers: a cross-sectional, hospital-based study in Montserrado County, Liberia. Save